Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricMBXMBX Biosciences IncALMSAlumis IncAMLXAmylyx Pharmaceuticals Inc
Snapshot
Price$67.38$24.93$38.16
Market cap$0.00$0.00$0.00
Valuation
P/E———
Forward P/E———
Growth
Revenue growth———
EPS growth———
Profitability
Net margin———
ROE———
Balance sheet & cash
Debt / equity———
Free cash flow yield———
Dividend yield———
Verdict
Investment ratingNot ratedNot ratedNot rated

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearMBXtoday $67ALMStoday $25AMLXtoday $38
2027$54.07 – $79.31+18% CAGR$20.01 – $29.34+18% CAGR$30.62 – $44.91+18% CAGR
2028$57.86 – $84.86+12% CAGR$21.41 – $31.40+12% CAGR$32.77 – $48.06+12% CAGR
2029$61.91 – $90.80+10% CAGR$22.91 – $33.59+10% CAGR$35.06 – $51.42+10% CAGR
2030$66.24 – $97.15+10% CAGR$24.51 – $35.95+10% CAGR$37.51 – $55.02+10% CAGR
2031$70.88 – $103.95+9% CAGR$26.22 – $38.46+9% CAGR$40.14 – $58.87+9% CAGR
5-yr CAGR1.0% – 9.1%1.0% – 9.1%1.0% – 9.1%